Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00867425 · ClinicalTrials.gov registry record · NA

Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program

A NA study of Obesity and Diabetes, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00867425: Completed NA study of Obesity and Diabetes, sponsored by University of Pittsburgh.

NCT00867425 is a NA study of Obesity and Diabetes that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00867425, a NA study of Obesity and Diabetes, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the effectiveness of Virtual Lifestyle Management (VLM) as a behavior modification tool to promote weight loss, healthy eating and physical activity patterns, in the interest of reducing risk and adverse outcomes for individuals at high risk of type 2 diabetes (T2D) and cardiovascular disease (CVD) in a military population. Specific Aim: To evaluate the effect of VLM on cardiovascular risk status in participants at high risk or individuals with T2D enrolled in the pilot study. The investigators hypothesize that participants will show greater improvement in weight as well as glucose, blood pressure, lipids, and self-reported diet and physical activity than will similar patients who are not enrolled in VLM.

Interventions

  • BEHAVIORAL Virtual Lifestyle Management

Study Locations (1)

Texas

  • Wilford Hall Medical Center - Lackland Air Force Base

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-04
Est. Completion 2010-03
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT00867425 record still lists

NCT00867425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Virtual Lifestyle Management is the first listed.

NCT00867425 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00867425 about?

NCT00867425 is a clinical study titled "Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program". The objective of this study is to evaluate the effectiveness of Virtual Lifestyle Management (VLM) as a behavior modification tool to promote weight loss, healthy eating and physical activity patterns, in the interest of reducing risk and adverse outcomes for individuals at high risk of type 2 diabe...

What is the current status of trial NCT00867425?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2009-04. Estimated completion is 2010-03.

What conditions does trial NCT00867425 study?

This clinical trial studies the following conditions: Obesity, Diabetes, Cardiovascular Disease.

What interventions are being tested in trial NCT00867425?

The interventions under investigation include: Virtual Lifestyle Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00867425?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00867425 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00867425's enrollment target sits among peer trials

30 851st of 1053 higher than 173 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00867425, the US trial registry maintained by the National Library of Medicine. NCT00867425 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.